Biosensors International

Biosensors International Group is a medical device company headquartered in Singapore, specializing in developing, manufacturing, and licensing technologies for interventional cardiology procedures and critical care. The company aims to optimize patient outcomes through innovative products designed for use in these high-stakes medical fields. Established in 2005, Biosensors International has a significant global presence, with European headquarters in Morges, Switzerland.

Biosensors International has achieved notable success since its inception, including being listed on the Mainboard of the Singapore Exchange (SGX) in May 2005. The company has expanded its reach globally, establishing key facilities and R&D centers in Singapore and Switzerland. Its commitment to innovation and patient care has positioned it as a leader in the medical device industry, particularly in interventional cardiology.